Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 2186

Original article / research
Table of Contents - Year : 2018 | Month : August | Volume : 12 | Issue : 8 | Page : FC10 - FC13

Screening and Assessment of Polyneuropathy in Diabetic Patients and the Effect of Vitamin B12 Administration on the Course of Neuropathy FC10-FC13

Alpesh Chauhan, Ashwini Patil, Uma Bhosale, Shreepad Bhat

Dr. Alpesh Chauhan,
Assistant Professor, Department of Pharmacology, Gujarat Adani Institute of Medical Sciences, Bhuj-370001, Gujarat, India.
E-mail: alpeshkch auhan@g

Introduction: Diabetic polyneuropathy is a specific form of axonal neuropathy that includes peripheral neuropathy of sensory nerve fibers with eventual autonomic and motor involvement. Screening and identification of polyneuropathy offers a crucial opportunity to prevent further complications by using vitamin B12.

Aim: To assess the occurrence of polyneuropathy in patients with type I and type II diabetes mellitus and evaluate the effect of vitamin B12 administration on the course of polyneuropathy.

Materials and Methods: This prospective open label study carried out in 50 patients in medicine Outpatient Department (OPD) at Smt. Kashibai Navale Medical College and General Hospital, tertiary care hospital in Pune, Maharashtra, India from June 2016 to June 2017, after obtaining Institutional Ethics Committee approval and informed consent from participants. Fifty patients, aged 18-60 years of type I and type II diabetes mellitus were screened for polyneuropathy from June 2016 to June 2017. Thirty two out of 50 patients showed evidence of neuropathy based on either of the parameters including Diabetic Neuropathy Symptom (DNS) questionnaire; Survey of Autonomic Symptoms (SAS) questionnaire; standardized nerve conduction studies and peripheral neuropathy testing {ankle reflex and Diabetic Neuropathy Examination (DNE). These 32 patients were given a tablet methylcobalamin 1.5 mg daily for three months after which all the above parameters were repeated to evaluate the course of neuropathy by paired t-test.

Results: Mean baseline DNS score was 1.630.75 which was improved significantly (p=0.032) to 1.410.80 after three month methylcobalamin treatment. Mean baseline SAS score was 4.942.60 while post methylcobalamin therapy it was 4.592.39, suggesting significant improvement (p=0.009). Nerve conduction velocity of ulnar nerve in every patient was normal before and after methylcobalamin therapy. Mean baseline DNE score (3.341.73) improved significantly (p=0.027) to 3.061.54 after completing three months of methylcobalamin therapy.

Conclusion: Strong positive association found between diabetes-Vitamin B12 deficiency and polyneuropathy. Administration of methylcobalamin therapy is warranted as significantly improved symptoms of polyneuropathy in diabetic patients.